Found 534 hits.
| 420. | Weller, K.+, Giménez-Arnau, A., Grattan, C., Asero, R., Mathelier-Fusade, P., Bizjak, M., Hanna, M., and Maurer, M.: The chronic urticaria registry: rationale, methods, and initial implementation. J. Eur. Acad. Dermatol. Venereol. 2021: 35; 721-729. IF: 9.23 |
o.420
| 179 | Aberer, W.+, Maurer, M. Reshef, A., Longhurst, H., Kivity, S., Bygum, A., Caballero, T., Bloom, B., Nair, N., and Malbrán, A.: Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema. Allergy 2014: 69; 305-314. IF: 6.03 |
| 399. | Kröger, M., Scheffel, J., Nikolaev, V. V., Shirshin, E. A., Siebenhaar, F., Schleusener, J., Lademann, J., Maurer, M., and Darvin, M. E.+: In vivo non-invasive staining-free visualization of dermal mast cells in healthy, allergy and mastocytosis humans using two-photon fluorescence lifetime imaging. Sci. Rep. 2020: 10; 14930. IF: 4.38 |
o.399
| 247 | Azar, R. P.+, Thomas, A. H., Maurer, M. and Lindner, G.: Alterations in hair follicle morphology and hair shaft production after follicular unit transplantation. Am. J. Dermatopathol. 2016: 38; 732-738. IF: 1.09 |
| 135 | Krause, K., Weller, K., Stefaniak, R., Wittkowski, H., Altrichter, S., Siebenhaar, F., Zuberbier, T., and Maurer, M.+: Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: An open-label study. Allergy 2012: 67; 943-950. IF: 6.27 |
| 425. | Bizjak, M., Košnik, M., Terhorst-Molawi, D., Dinevski, D., and Maurer, M.+: Cold agglutinins and cryoglobulins associate with clinical and laboratory parameters of cold urticaria. Front. Immunol. 2021: 12; 665491. IF: 8.79 |
o.425
| 347 | Cherrez-Ojeda, I.+, Maurer, M., Bernstein, J. A., Vanegas, E., Felix, M., Ramon, G. D., Ensina, L. F., Larco Sousa, J. I., Matos Benavides, E. E., Cardona Villa, R., Latour Staffeld, P., Morfin-Maciel, B. M., Mori, J., Wilches, P. C.; Mata, V. L., and Cherrez, A.: Learnings from real-life experience of using omalizumab for chronic urticaria in Latin America. World Allergy Organ. J. 2019: 12; 100011. IF: TBD (IF 2018: 3.68) |
o.347
| 26 | Gommerman, J. L., Oh, D. Y., Zhou, X., Tedder, T. F., Maurer, M. Galli, S. J., and Carroll, M. C.+: A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation. J. Immunol. 2000: 165; 6915-6921. IF: 6.83 |
o.026
Personal Background Prof. Dr. med. Marcus Maurer Executive Director of the Institute of Allergology at the Charité – Universitätsmedizin Berlin Co-Director of Immunology and Allergology at the
| 187 | Weller, K., Groffik, A., Church, M. K., Hawro, T., Krause, K., Metz, M., Martus, P., Casale, T., Staubach, P., and Maurer, M.+: Development and validation of the urticaria control test – a patient reported outcome instrument for assessing urticaria control. J. Allergy Clin. Immunol. 2014: 133; 1365-1372. IF: 11.47 |